Suchergebnisse - "De Jong, Dirk"

PubPharm (212)

11

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Biemans, V. | van der Woude, C. | Dijkstra, G. | +14

CommentIn: Aliment Pharmacol Ther. 2020 Aug;52(4):753-754. - PMID 32886363

12

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Kreijne, J. | de Vries, A. | de Veer, R. | +9

CommentIn: Aliment Pharmacol Ther. 2020 Sep;52(5):910. - PMID 32852819

13

Vedolizumab for Inflammatory Bowel Disease : Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab

enthalten in: Clinical pharmacology and therapeutics | 2020

von Biemans, V. | van der Woude, C. | Dijkstra, G. | +13

14

Ustekinumab for Crohn's Disease : Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Biemans, V. | van der Meulen-de Jong, A. | van der Woude, C. | +12

15

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease : myelotoxicity and hepatotoxicity rarely affect maintenance treatment

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Kreijne, J. | de Veer, R. | de Boer, N. | +7

16

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2019

von Sluiter, R. | Van Marrewijk, C. | De Jong, D. | +11

17

Forewarning of hypotensive events using a Bayesian artificial neural network in neurocritical care

enthalten in: Journal of clinical monitoring and computing | 2019

von Donald, R. | Howells, T. | Piper, I. | +47

18

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients : Two-year Follow-up of a Prospective Observational Cohort Study

enthalten in: Inflammatory bowel diseases | 2019

von Smits, L. | van Esch, A. | Derikx, L. | +4

19

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease

enthalten in: Journal of Crohn's & colitis | 2018

von Visschedijk, M. | Spekhorst, L. | Cheng, S. | +21

20

Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases

enthalten in: European journal of gastroenterology & hepatology | 2018

von Broekman, M. | Coenen, M. | Wanten, G. | +11